Profile data is unavailable for this security.
About the company
Sigyn Therapeutics, Inc. (Sigyn) is a development-stage company. The Company is focused on creating therapeutic solutions that address unmet needs in global health. The Company's product candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Its treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy (CRRT) machines. The Company’s development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis.
- Revenue in USD (TTM)0.00
- Net income in USD-3.70m
- Incorporated2014
- Employees5.00
- LocationSigyn Therapeutics Inc9190 W Olympic Blvd # 263BEVERLY HILLS 90212United StatesUSA
- Phone+1 (619) 368-2000
- Fax+1 (845) 818-3588
- Websitehttps://www.sigyntherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dalrada Financial Corporation | 32.16m | -21.34m | 6.79m | 0.00 | -- | 0.7687 | -- | 0.2111 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
| Neurometrix Inc | 4.38m | -7.94m | 7.54m | 26.00 | -- | 0.4333 | -- | 1.72 | -5.50 | -5.50 | 2.91 | 8.58 | 0.2102 | 1.15 | 8.53 | 168,600.80 | -38.06 | -23.24 | -40.80 | -27.26 | 60.19 | 59.17 | -181.03 | -48.88 | 10.71 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
| Biotricity Inc | 12.24m | -18.28m | 7.63m | 55.00 | -- | -- | -- | 0.6235 | -1.74 | -1.74 | 1.18 | -1.27 | 2.12 | 1.67 | 8.08 | 222,624.00 | -248.61 | -269.25 | -- | -- | 71.89 | 58.93 | -117.41 | -258.94 | 0.106 | -0.6408 | -- | -- | 25.15 | 97.82 | 23.57 | -- | -- | -- |
| Cutera Inc | 169.19m | -148.97m | 7.82m | 430.00 | -- | -- | -- | 0.0462 | -7.46 | -7.46 | 8.46 | -10.73 | 0.4572 | 2.08 | 3.86 | 393,460.50 | -40.25 | -22.00 | -51.64 | -30.72 | 8.18 | 47.63 | -88.05 | -27.24 | 2.17 | -31.34 | 2.05 | -- | -15.86 | 5.47 | -97.76 | -- | 85.87 | -- |
| Precipio Inc | 16.72m | -3.83m | 9.04m | 51.00 | -- | 0.7399 | -- | 0.5407 | -2.68 | -2.68 | 11.73 | 8.24 | 0.9089 | 17.12 | 16.80 | 327,843.10 | -20.82 | -44.98 | -27.94 | -58.68 | 39.08 | 28.80 | -22.90 | -118.07 | 0.590 | -192.59 | 0.0517 | -- | 61.46 | 39.62 | 52.04 | -- | 5.37 | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.70m | 9.15m | 5.00 | -- | -- | -- | -- | -3.08 | -3.08 | 0.00 | -2.91 | 0.00 | -- | -- | 0.00 | -1,085.72 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0247 | -2.09 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| ALR Technologies Inc | 9.49k | -8.00m | 9.21m | 6.00 | -- | -- | -- | 970.95 | -0.0147 | -0.0147 | 0.00002 | -0.0476 | 0.0358 | -- | -- | 1,581.67 | -3,015.28 | -12,861.64 | -- | -- | 62.49 | -- | -84,283.24 | -406,011.30 | -- | -0.8626 | -- | -- | -- | -- | -42.72 | -- | -- | -- |
| Applied DNA Sciences Inc | 3.40m | -7.52m | 9.64m | 53.00 | -- | 0.1587 | -- | 2.84 | -11.86 | -11.86 | 2.18 | 1.20 | 0.2092 | 6.83 | 5.68 | 64,114.15 | -45.51 | -88.57 | -55.20 | -121.91 | 25.04 | 44.35 | -217.48 | -113.26 | 3.76 | -- | 0.00 | -- | -26.43 | 27.92 | -18.73 | -- | 33.80 | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 10.14m | 113.00 | -- | -- | -- | 1.41 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| Scientific Industries Inc | 10.45m | -7.76m | 10.50m | 63.00 | -- | 0.8992 | -- | 1.00 | -0.9231 | -0.9231 | 1.17 | 1.11 | 0.7343 | 1.13 | 9.08 | 165,942.90 | -54.50 | -- | -62.11 | -- | 45.41 | -- | -74.22 | -- | 3.15 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| REMSleep Holdings Inc | 144.88k | -1.81m | 10.64m | 6.00 | -- | 18.50 | -- | 73.42 | -0.0012 | -0.0012 | 0.0001 | 0.0004 | 0.08 | 1.69 | 4.75 | -- | -99.82 | -152.40 | -122.32 | -317.98 | -491.08 | -- | -1,246.94 | -2,317.52 | 1.47 | -43.58 | 0.1207 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 10.94m | -- | -- | 0.5029 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| PetVivo Holdings Inc | 975.28k | -10.11m | 11.19m | 20.00 | -- | 13.43 | -- | 11.48 | -0.6705 | -0.6705 | 0.062 | 0.0417 | 0.3257 | 0.405 | 16.37 | 48,764.00 | -337.63 | -230.77 | -589.09 | -467.99 | 83.60 | 66.21 | -1,036.50 | -1,501.44 | 0.455 | -1,075.05 | 0.0221 | -- | 5.62 | -- | -25.67 | -- | 23.91 | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.23m | 11.39m | 12.00 | -- | -- | -- | -- | -21.41 | -21.41 | 0.00 | -2.14 | 0.00 | -- | -- | 0.00 | -1,145.80 | -- | -- | -- | -- | -- | -- | -- | -- | -9.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Innovative Eyewear Inc | 1.53m | -7.86m | 11.50m | 11.00 | -- | 1.52 | -- | 7.52 | -11.01 | -11.01 | 2.05 | 4.81 | 0.1779 | 1.97 | 15.91 | 139,070.90 | -91.45 | -- | -96.06 | -- | -2.46 | -- | -514.10 | -- | 12.85 | -- | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| PAVmed Inc | 3.83m | -67.35m | 11.55m | 107.00 | -- | -- | -- | 3.02 | -8.17 | -8.17 | 0.4595 | -7.74 | 0.0823 | -- | 29.45 | 35,785.05 | -155.93 | -154.56 | -- | -1,152.82 | -77.59 | -- | -1,895.64 | -8,764.89 | 0.5529 | -8.16 | 1.74 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
Data as of Nov 05 2024. Currency figures normalised to Sigyn Therapeutics Inc's reporting currency: US Dollar USD
0.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brio Capital Management LLCas of 09 Jan 2024 | 2.15k | 0.17% |
Data from 28 Aug 2024 - 28 Aug 2024Source: FactSet Research Systems Inc.
